| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 174.85B | 191.57B | 192.43B | 171.91B | 115.05B | 93.85B |
| Gross Profit | 110.47B | 107.42B | 96.07B | 94.19B | 92.41B | 93.71B |
| EBITDA | 41.74B | 40.01B | 31.44B | 30.40B | 32.95B | 35.87B |
| Net Income | 31.70B | 30.51B | 27.13B | 26.52B | 27.53B | 31.98B |
Balance Sheet | ||||||
| Total Assets | 3.50T | 3.41T | 3.26T | 3.18T | 3.05T | 3.17T |
| Cash, Cash Equivalents and Short-Term Investments | 249.87B | 963.73B | 642.92B | 608.07B | 458.25B | 654.54B |
| Total Debt | 383.59B | 365.90B | 658.43B | 618.19B | 498.55B | 496.20B |
| Total Liabilities | 3.20T | 3.11T | 2.97T | 2.89T | 2.78T | 2.90T |
| Stockholders Equity | 300.67B | 303.24B | 295.56B | 291.65B | 273.20B | 270.07B |
Cash Flow | ||||||
| Free Cash Flow | 56.57B | 12.61B | -8.80B | 44.98B | -6.33B | -7.19B |
| Operating Cash Flow | 56.57B | 12.61B | -8.80B | 44.98B | -6.33B | -7.19B |
| Investing Cash Flow | -122.60B | -145.16B | -90.69B | -35.39B | -2.53B | -313.29B |
| Financing Cash Flow | 33.03B | 69.95B | 60.37B | 93.34B | -106.04B | 291.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $805.81B | 12.43 | 16.32% | 1.79% | 1.33% | 2.47% | |
73 Outperform | $307.76B | 9.62 | 12.07% | 4.14% | -6.12% | 12.49% | |
72 Outperform | $359.73B | 10.30 | 10.50% | 1.93% | -1.69% | 20.90% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $209.92B | 8.51 | 7.53% | 1.94% | 3.02% | 27.74% | |
65 Neutral | $227.59B | 11.96 | 12.04% | 1.80% | 1.28% | 16.35% | |
64 Neutral | $279.18B | 11.41 | 14.58% | 1.55% | 2.63% | 26.98% |